Literature DB >> 2298485

Induction of circulating tumor necrosis factor cannot be demonstrated during septicemic salmonellosis in calves.

J E Peel1, M J Voirol, C Kolly, D Gobet, S Martinod.   

Abstract

The concentration of tumor necrosis factor in the circulation of calves, which were infected with Salmonella typhimurium and exhibited septicemia as indicated by clinical signs and blood culture, was measured with a radioimmunoassay. These levels were compared with those in calves before infection and in other calves that had received an intravenous dose of gram-negative endotoxin. The tumor necrosis factor levels measured in samples taken during septicemia were not different from those in samples from infected nonsepticemic calves or samples from calves before infection. In contrast, the levels of tumor necrosis factor rose rapidly in calves after treatment with endotoxin by intravenous injection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298485      PMCID: PMC258476          DOI: 10.1128/iai.58.2.439-442.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Pathophysiological effects of endotoxins in ruminants. 1. Changes in body temperature and reticulo-rumen motility, and the effect of repeated administration.

Authors:  J A Lohuis; J H Verheijden; C Burvenich; A S van Miert
Journal:  Vet Q       Date:  1988-04       Impact factor: 3.320

2.  Bacterial-lipopolysaccharide-induced release of lactoferrin from human polymorphonuclear leukocytes: role of monocyte-derived tumor necrosis factor alpha.

Authors:  P Koivuranta-Vaara; D Banda; I M Goldstein
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Authors:  S N Vogel; E N Kaufman; M D Tate; R Neta
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Quantitative analysis and partial characterization of cytotoxin production by Salmonella strains.

Authors:  S Ashkenazi; T G Cleary; B E Murray; A Wanger; L K Pickering
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

Review 7.  Natural production and release of tumour necrosis factor.

Authors:  G E Gifford; D A Flick
Journal:  Ciba Found Symp       Date:  1987

8.  Bovine salmonellosis: experimental production and characterization of the disease in calves, using oral challenge with Salmonella typhimurium.

Authors:  B P Smith; F Habasha; M Reina-Guerra; A J Hardy
Journal:  Am J Vet Res       Date:  1979-11       Impact factor: 1.156

9.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

10.  Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity.

Authors:  D L Fraker; M C Stovroff; M J Merino; J A Norton
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Bacteraemia in man and animals: an overview.

Authors:  J Vaid
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

2.  Administration of bacterial lipopolysaccharide elicits circulating tumor necrosis factor-alpha in neonatal calves.

Authors:  J L Adams; S D Semrad; C J Czuprynski
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

3.  Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.

Authors:  H R Alexander; B C Sheppard; J C Jensen; H N Langstein; C M Buresh; D Venzon; E C Walker; D L Fraker; M C Stovroff; J A Norton
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Inhibition of lipopolysaccharide-associated endotoxin activities in vitro and in vivo by the human anti-lipid A monoclonal antibody SdJ5-1.17.15.

Authors:  I S Fang; M A Wisniewski; C C Huntenburg; L S Knight; J E Bubbers; M J Schneidkraut
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Regulation of bovine acute phase responses by recombinant interleukin-1 beta.

Authors:  D L Godson; M E Baca-Estrada; A G Van Kessel; H P Hughes; M A Morsy; J Van Donkersgoed; R J Harland; D E Shuster; M J Daley; L A Babiuk
Journal:  Can J Vet Res       Date:  1995-10       Impact factor: 1.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.